【財華社訊】港交所權益資料顯示,昭衍新藥(06127.HK)獲Aggregate of abrdn plc affiliated investment management entities於11月11日在場內以每股平均價82.325港元增持21.20萬股,涉資約1745.29萬港元。增持後,Aggregate of abrdn plc affiliated investment management entities的最新持股數目為308.32萬股,持股比例由4.73%增持至5.08%。(出處:FinetAI)
港交所原文